Exam date announced for Pharmacists by GSSSB
24 July 2026

Exam date announced for Pharmacists (266 posts) by GSSSB | Full syllabus for exam and detailed information

Board Advertisement No.: 415/202627, Junior Pharmacist, Class-3 Cadre Published Advertisement  

Important Notice Regarding Competitive Test Date
Gujarat Subordinate Services Selection Board has decided to organize the examination through MCQ CBRT method for the advertisement mentioned in the sheet below under direct recruitment.  
Notifications regarding the call-letter of MCQ - CBRT examination will be published on the Board's website later.

Career for Pharmacists in All India Institute of Medical Sciences
24 July 2026
Career for Pharmacists in All India Institute of Medical Sciences
Officers under the Central/State/U.T. Governments/ Universities/Statutory Bodies or Autonomous Bodies or Research and Development Organizations i. holding analogous posts on regular basis
Recruitment for Pharmacists (05 posts) at Oil India Limited
24 July 2026
Recruitment for Pharmacists (05 posts) at Oil India Limited
Must have passed 02 years Diploma Course in Pharmacy from an Institute recognized by Government of India and the Pharmacy Council of India. 
Research Fellowships for Pharma and Science candidates under KCSTC, ISRO at IIT KHARAGPUR
24 July 2026
Research Fellowships for Pharma and Science candidates under KCSTC, ISRO at IIT KHARAGPUR

The history of the IIT system dates back to 1946 when a committee was set up by Hon'ble Sir Jogendra Singh, Member of the Viceroy's Executive Council, Department of Education, Health and Agriculture to consider the setting up of Higher Technical Institutions for post war industrial development in India.

ECHS Polyclinic Kota invites applications for post of Pharmacist
24 July 2026
ECHS Polyclinic Kota invites applications for post of Pharmacist
B.Pharmacy from recognized Institute or 10 plus 2 with science stream Physics, Chemistry & Biology from a recognized board, Approved Diploma in Pharmacy from an Institute recognized by the Pharmacy council of India
Interview for Pharmacist at Homi Bhabha Cancer Hospital and Research Centre
24 July 2026
Interview for Pharmacist at Homi Bhabha Cancer Hospital and Research Centre
Diploma in Pharmacy from a recognized institution and registered as pharmacist OR Bachelor Degree in Pharmacy (B. Pharm) from a recognized institution and registered as Pharmacist under the Pharmacy act 1948 and one year experience as pharmacist in any recognized hospital or pharmacy after registration as pharmacist under the Pharmacy act 1948.
Advertisement for Principal, Professor, Associate Professor, Assistant Professor at Yashodeep College of Pharmacy
24 July 2026
Advertisement for Principal, Professor, Associate Professor, Assistant Professor at Yashodeep College of Pharmacy
Educational Qualifications, Experience, Pay Scale etc. applicable for the respective post shall be as per norms specified by AICTE / PCI / COA, Govt. of Maharashtra and Dr. Babasaheb Ambedkar Technological University (DBATU), Lonere, as modified from time to time.
Pharmacy graduates apply now for ANRF Project, IIT Kharagpur
24 July 2026
Pharmacy graduates apply now for ANRF Project, IIT Kharagpur
Four years Bachelors Degree in Natural or Agricultural Sciences / Masters Degree in Natural or Agricultural Sciences / BVSc/BPharm or Bachelors degree in Engineering or Technology or Medicine or from a recognized University or equivalent
EU Panel Backs Roche’s Susvimo, Opening New Era for Continuous AMD Treatment
24 July 2026
EU Panel Backs Roche’s Susvimo, Opening New Era for Continuous AMD Treatment

Roche has announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending the approval of Susvimo® (ranibizumab) for the treatment of neovascular age-related macular degeneration (nAMD). If the European Commission grants final approval, Susvimo will become the first continuous drug-delivery treatment for nAMD in the European Union.

US FDA Warns Almon Healthcare Over Serious API GMP Lapses
24 July 2026
US FDA Warns Almon Healthcare Over Serious API GMP Lapses

The U.S. Food and Drug Administration (US FDA) has issued a Warning Letter to Almon Healthcare Private Limited, Ahmedabad, Gujarat, after identifying significant violations of Current Good Manufacturing Practice (CGMP) regulations at its active pharmaceutical ingredient (API) manufacturing facility during an inspection conducted from February 9–13, 2026. The warning letter was issued on July 13, 2026.